• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

1NM-PP1

CAS No. 221244-14-0

1NM-PP1 ( PP1 Analog II )

产品货号. M13527 CAS No. 221244-14-0

1NM-PP1(PP1 Analog II) 是一种细胞渗透性 PP1 类似物,可作为突变激酶对其野生型祖细胞的有效和选择性抑制剂 (IC50=28 uM vSrc; 4.2 nM v-Src-as1 I338G)。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥436 有现货
5MG ¥696 有现货
10MG ¥1074 有现货
25MG ¥2223 有现货
50MG ¥3506 有现货
100MG ¥4851 有现货
500MG 获取报价 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥751 有现货

生物学信息

  • 产品名称
    1NM-PP1
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    1NM-PP1(PP1 Analog II) 是一种细胞渗透性 PP1 类似物,可作为突变激酶对其野生型祖细胞的有效和选择性抑制剂 (IC50=28 uM vSrc; 4.2 nM v-Src-as1 I338G)。
  • 产品描述
    1NM-PP1(PP1 Analog II) is a cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors(IC50=28 uM vSrc; 4.2 nM v-Src-as1 I338G).
  • 体外实验
    Cdk7 from Cdk7as/as or Cdk7+/+ cells is immunoprecipitated and tested its kinase activity towards both a Pol II CTD-containing fusion protein (GST-CTD) and human Cdk2. Cdk7 recovered from the mutant, but not the wild-type, cells is inhibited by 1-NM-PP1 (1-NMPP1), with an IC50 of ~50 nM with either substrate. Replacement of wild-type Cdk7 with Cdk7as/as also rendered growth of HCT116 cells sensitive to 1-NM-PP1. In the absence of 1-NM-PP1, the wild-type andCdk7as/as cells had population doubling times of ~17.9 and ~20.2 h, respectively, with similar cell-cycle distributions in asynchronous culture, indicating minimal impairment of Cdk7 function by the F91G mutation per se. The homozygous Cdk7as/as cells are sensitive to 1-NM-PP1, however, with an IC50 ~100 nM measured by cell viability (MTT) assays performed after 96 h of 1-NM-PP1 exposure. In contrast, wild-type HCT116 cells are resistant to 10 μM 1-NM-PP1. Addition of 10 μM 1-NM-PP1 retards G1/S progression by the mutant but not the wild-type cells. When added simultaneously with serum to the Cdk7as/as cells, 1-NM-PP1 prevents any progression into S phase in the next 15 h. After 24 h, there is evidence of progression into S-phase by a fraction of Cdk7as/as cells released from serum starvation directly into medium containing 1-NM-PP1, while a fraction remained in G1. The addition of 1-NM-PP1 3 h or 6 h after serum addition delays S-phase entry by ~7 h or by ~3 h, respectively.
  • 体内实验
    ——
  • 同义词
    PP1 Analog II
  • 通路
    Angiogenesis
  • 靶点
    CDK
  • 受体
    CDK7
  • 研究领域
    Cancer
  • 适应症
    ——

化学信息

  • CAS Number
    221244-14-0
  • 分子量
    331.41
  • 分子式
    C20H21N5
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO: 10 mM
  • SMILES
    NC1=C2C(N(C(C)(C)C)N=C2CC3=C4C=CC=CC4=CC=C3)=NC=N1
  • 化学全称
    1-(tert-butyl)-3-(naphthalen-1-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Papa FR, et al. Science. 2003 Nov 28;302(5650):1533-7.
产品手册
关联产品
  • NU-6102

    一种有效的 CDK1 和 CDK2 抑制剂,对 CDK1/cyclinB 和 CDK2/cyclinA3 的 IC50 分别为 9.5 nM 和 5.4 nM。

  • SEL120-34A hydrochlo...

    SEL120-34A 是一种 ATP 竞争性、选择性、口服活性 CDK8 抑制剂,可抑制 CDK8/CycC 和 CDK19/CycC 复合物的激酶活性,IC50 分别为 4.4 nM 和 10.4 nM。

  • CDK4/6-IN-2

    CDK4/6-IN-2 是一种有效的 CDK4 和 CDK6 抑制剂(IC50:2.7 和 16 nM),源自专利 US20180000819A1(化合物 1)。